Suissa, K. ., Schneeweiss, S. ., Douros, A. ., Yin, H. ., Patorno, E. ., & Azoulay, L. . (2022). Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes. Diabetes Res Clin Pract, 192, 110094. http://doi.org/10.1016/j.diabres.2022.110094
Sodium-glucose cotransporter-2 inhibitors
Eroglu, T. E., Coronel, R. ., Zuurbier, C. J., Blom, M. ., de Boer, A. ., & Souverein, P. C. (2022). Use of sodium-glucose cotransporter-2 inhibitors and the risk for sudden cardiac arrest and for all-cause death in patients with type 2 diabetes mellitus. Eur Heart J Cardiovasc Pharmacother. http://doi.org/10.1093/ehjcvp/pvac043
Pradhan, R. ., Patorno, E. ., Tesfaye, H. ., Schneeweiss, S. ., Yin, H. ., Franklin, J. ., … Azoulay, L. . (2022). Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study. Am J Epidemiol. http://doi.org/10.1093/aje/kwac021